Search Results 261-270 of 18341 for IUD

1. Azacitidine and Sonidegib in Treating Patients With Myeloid Malignancies - Mayo Clinic

   Placement of a non-hormonal intrauterine device (IUD) or nonhormonal intrauterine system (IUS); Barrier method of contraception: condom or occlusive cap ...

2. Double uterus - Doctors and departments - Mayo Clinic

   ... Intrauterine device method, Hysterosco...py, Fertility preservation, Genetic counseling, Gestational surrogacy, Sperm freezing, Intracytoplasmic sperm ...

3. Chronic pelvic pain - Doctors and departments - Mayo Clinic

   ... Intrauterine device method, CO-2 laser treatment, Conization, Polypectomy, Gynecological surgery, HPV infection, Endometriosis, Uterine fibroid, Menstrual ...

4. A Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial

   Hormonal methods of contraception including combined oral contraceptive pills, vaginal ring, injectables, implants and intrauterine devices (IUDs) such as ...

5. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   Established intrauterine device (IUD) or intrauterine hormone releasing system (IUS);; Vasectomy (a vasectomy is a highly effective contraception method ...

6. Vaccine Therapy and Resiquimod in Treating Patients with Stage II-IV Melanoma that has been Removed by Surgery - Mayo Clinic

   ... intrauterine device [IUD], surgical sterilization, subcutaneous implants, or abstinence, etc.) Known immune deficiency, including human immunodeficiency ...

7. CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin - Mayo Clinic

   Acceptable methods of contraception include intrauterine device (IUD), oral contraceptive, subdermal implant, double barrier and/or complete abstinence (non- ...

8. Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection - Mayo Clinic

   ... intrauterine device (IUD), or use of spermicide combined with a barrier method (e.g., condom, diaphragm) through Day 365. Exclusion Criteria: PJI associated ...

9. A Patient Access Program of Olaratumab for the Continued Treatment of Soft Tissue Sarcoma - Mayo Clinic

   ... (IUDs), sexual abstinence, or a vasectomized partner. Exclusion Criteria: Breastfeeding (patients who discontinue breastfeeding would be considered eligible) ...

10. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    ... Intrauterine device (IUD) -Double-barrier method: male condom plus diaphragm or vaginal cap with spermicide (contraceptive sponge, jellies or creams) ...